Immune Mediated and Cholestatic Diseases programme overview

Immune Mediated and Cholestatic Diseases are a rapidly evolving field, and we are thrilled to present new data from large multicentre cohorts, as well as exciting developments in drug targeting for immune and genetic cholestasis. At EASL Congress 2023, you will have the opportunity to interact with other experts, get the latest news, and share experiences on how to manage patients with these rare diseases.

Networking is essential for rare diseases, and this is the perfect place to connect with your peers from other countries, and put together data from large cohorts to learn and offer our patients the best management and treatment options.